13F-HR filed by NEA Management Company, LLC
NEA Management Company, LLC filed this 13F-HR for the quarter ended 2017-03-31, filed 2017-05-10, with 38 holding rows worth $2,875,271,000.
- Accession
- 0001012975-17-000376
- Filer
- CIK 1512848
- Filed
- 2017-05-10
- Accepted by EDGAR
- acceptance time not in the bulk data set
- Ingested
- Source
- SEC quarterly data set
13F report for Q1 2017
A holdings report, 38 entries on the cover page, a total value of $2,875,271,000 stated on the cover page (in dollars after the unit check, H1), rows summing to $2,875,271,000 with VALUE read as thousands by filing date, 13F file number 028-14302. The quarter's positions are built on this report. The resolved quarter.
The information table after summing rows of one CUSIP and put or call (H4), with the CUSIP and issuer name as filed. Values in dollars after the unit check (method).
| Issuer as filed | CUSIP | Class | Amount | Value | Value read as | Type |
|---|---|---|---|---|---|---|
| TESARO INC | 881569107 | COM | 10,275,113 | $1,581,032,000 | thousands by filing date | |
| ARDELYX INC | 039697107 | COM | 14,083,582 | $178,157,000 | thousands by filing date | |
| ACHAOGEN INC | 004449104 | COM | 5,215,128 | $131,578,000 | thousands by filing date | |
| DERMIRA INC | 24983L104 | COM | 3,506,649 | $119,612,000 | thousands by filing date | |
| EPIZYME INC | 29428V104 | COM | 6,260,851 | $107,374,000 | thousands by filing date | |
| RA PHARMACEUTICALS INC | 74933V108 | COM | 3,493,636 | $74,380,000 | thousands by filing date | |
| CRISPR THERAPEUTICS AG NAMEN AKT | H17182108 | Stock | 3,220,728 | $70,115,000 | thousands by filing date | |
| ADAPTIMMUNE THERAPEUTICS PLC | 00653A107 | SPONDS ADR | 12,025,999 | $66,263,000 | thousands by filing date | |
| GROUPON INC | 399473107 | COMMON STOCK | 15,056,822 | $59,173,000 | thousands by filing date | |
| SENSEONICS HLDGS INC | 81727U105 | COM | 26,305,286 | $47,086,000 | thousands by filing date | |
| GLYCOMIMETICS INC | 38000Q102 | COM | 8,584,128 | $46,612,000 | thousands by filing date | |
| CARE COM INC | 141633107 | COM | 3,260,989 | $40,795,000 | thousands by filing date | |
| CASCADIAN THERAPEUTICS INC | 14740B606 | COM NEW | 9,064,575 | $37,527,000 | thousands by filing date | |
| AURINIA PHARMACEUTICALS INC COM | 05156V102 | Stock | 4,808,483 | $35,294,000 | thousands by filing date | |
| ObsEva SA | H5861P103 | COM | 3,336,563 | $34,734,000 | thousands by filing date | |
| LEXICON PHARMACEUTICALS INC | 528872302 | COMMON STOCK | 2,382,286 | $34,162,000 | thousands by filing date | |
| NEVRO CORP | 64157F103 | COM | 359,678 | $33,702,000 | thousands by filing date | |
| PROTEOSTASIS THERAPEUTICS IN | 74373B109 | COM | 3,556,778 | $27,814,000 | thousands by filing date | |
| STRONGBRIDGE BIOPHARMA PLC | G85347105 | SHS USD | 4,141,308 | $19,671,000 | thousands by filing date | |
| HIVE | 007786106 | Stock | 4,309,691 | $18,144,000 | thousands by filing date | |
| ENDOLOGIX INC | 29266S106 | COM | 2,490,204 | $18,029,000 | thousands by filing date | |
| TREVENA INC | 89532E109 | COM | 3,811,691 | $13,989,000 | thousands by filing date | |
| RIGEL PHARMACEUTICALS INC | 766559603 | COMMON STOCK | 3,243,150 | $10,375,000 | thousands by filing date | |
| TRACON PHARMACEUTICALS INC | 89237H100 | COM | 2,759,217 | $10,347,000 | thousands by filing date | |
| AVEO PHARMACEUTICALS INC | 053588109 | COM | 16,362,694 | $9,654,000 | thousands by filing date | |
| AFFIMED N V | N01045108 | COM | 3,888,888 | $8,944,000 | thousands by filing date | |
| SYNLOGIC | 60470J103 | Stock | 2,974,811 | $6,515,000 | thousands by filing date | |
| DASAN ZHONE SOLUTIONS INC | 23305L206 | COM NEW | 956,255 | $5,972,000 | thousands by filing date | |
| SUNESIS PHARMACEUTICALS INC | 867328700 | COM | 1,298,274 | $5,323,000 | thousands by filing date | |
| AKARI THERAPEUTICS PLC | 00972G108 | ADR | 452,167 | $5,005,000 | thousands by filing date | |
| CHAMPIONS ONCOLOGY INC | 15870P307 | COM NEW | 1,562,500 | $4,953,000 | thousands by filing date | |
| ARCA BIOPHARMA INC | 00211Y407 | COM PAR | 1,460,209 | $3,724,000 | thousands by filing date | |
| ROKA BIOSCIENCE INC COM NEW | 775431208 | Stock | 893,471 | $3,181,000 | thousands by filing date | |
| ARQULE INC | 04269E107 | COM | 2,520,316 | $2,672,000 | thousands by filing date | |
| OREXIGEN THERAPEUTICS INC COM NEW | 686164302 | Stock | 370,900 | $1,276,000 | thousands by filing date | |
| PARATEK PHARMACEUTICALS INC | 699374302 | Equity | 66,245 | $1,275,000 | thousands by filing date | |
| CATALYST BIOSCIENCES INC | 14888D208 | COM | 43,492 | $410,000 | thousands by filing date | |
| CERECOR INC | 15671L109 | COM | 595,435 | $402,000 | thousands by filing date |
Amendment chain
| Filing | Role | Filed | Accepted | Ingested |
|---|---|---|---|---|
| 13F-HR 0001012975-17-000376 | this filing | 2017-05-10 | acceptance time not in the bulk data set |